This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Abbvie Deutschland Gmbh and Co Kg. Active years: 2005-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 826 
1 out of 4,188 
1 out of 167 
Years Active: 2005-2022
Title: Innovations by Yeshwant D. Sanzgiri: A Pioneer in Pharmaceutical Patents
Introduction
Yeshwant D. Sanzgiri is a distinguished inventor based in Gurnee, Illinois, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Sanzgiri's work primarily focuses on innovative drug formulations that address critical medical needs.
Latest Patents
Among his latest inventions, Sanzgiri holds a patent for "Melt-extruded solid dispersions containing an apoptosis-inducing agent." This innovative pro-apoptotic solid dispersion encompasses a Bcl-2 family protein inhibitory compound that is dispersed within a solid matrix. This matrix comprises a pharmaceutically acceptable water-soluble polymeric carrier and a surfactant. The new process involves heating the compound alongside the carrier and surfactant to create a semi-solid mixture that is extrudable, resulting in a solid formulation suitable for oral administration. Such a product targets diseases characterized by overexpression of anti-apoptotic Bcl-2 family proteins, presenting potential treatments for cancer and autoimmune diseases.
Additionally, Sanzgiri has developed the "ABT-263 capsule," which includes a pharmaceutical capsule encapsulating a liquid solution of ABT-263 or a pharmacologically acceptable salt. This capsule features a specially designed shell and utilizes a non-ethanolic carrier with various excipients, such as phospholipids and solubilizing agents. This invention also aims to treat ailments linked to the overexpression of anti-apoptotic Bcl-2 family proteins, emphasizing its application in cancer therapy.
Career Highlights
Sanzgiri has accumulated vast experience through his work at prominent pharmaceutical companies, including AbbVie Inc. and Abbott Laboratories Corporation. His tenure at these organizations allowed him to focus on research and development, where innovative drug solutions became the hallmark of his career. His endeavors have been critical in the pharmaceutical sector, driving advancements in treatment strategies.
Collaborations
Throughout his career, Sanzgiri has collaborated with esteemed colleagues such as Ping Tong and Deliang Zhou. Their combined expertise has contributed to the successful development of pharmaceutical innovations, highlighting the importance of teamwork in advancing science and technology within the industry.
Conclusion
Yeshwant D. Sanzgiri exemplifies the spirit of innovation in the pharmaceutical arena. With a focus on drug formulations targeting critical medical conditions, his patents represent significant strides in therapeutic development. His collaborations and career achievements underscore the vital role of inventors in shaping the future of medicine and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile